Diabetes and cardiovascular risk factors: the Framingham study

Cited by (109)

Items 101–109 of 109

1. Insulin Regulation of Proteostasis and Clinical Implications
   James, Haleigh A., O'Neill, Brian T., Nair, K. Sreekumaran · 2017 · Cell Metabolism
2. Glucose metabolism and coronary heart disease in patients with normal glucose tolerance
   Sasso, Ferdinando C. · 2004 · JAMA
3. C-Reactive Protein: Clinical and Epidemiological Perspectives
   Salazar, Juan, Martínez, María Sofía, Chávez, Mervin, Toledo, Alexandra, Añez, Roberto, Torres, Yaquelín, Apruzzese, Vanessa, Silva, Carlos, Rojas, Joselyn, Bermúdez, Valmore · 2014 · Cardiology Research and Practice
4. Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the Asia–Pacific region
   2007 · Journal of Hypertension
5. Relation of hypothyroidism and incident atrial fibrillation (from the Framingham Heart Study)
   Kim, Eun-Jeong, Lyass, Asya, Wang, Na, Massaro, Joseph M., Fox, Caroline S., Benjamin, Emelia J., Magnani, Jared W. · 2014 · American Heart Journal
6. Variation of fasting plasma glucose: A predictor of mortality in patients with type 2 diabetes
   Lin, Cheng-Chieh, Li, Chia-Ing, Yang, Sing-Yu, Liu, Chiu-Shong, Chen, Ching-Chu, Fuh, Martin Mao-Tsu, Chen, Walter, Li, Tsai-Chung · 2012 · The American Journal of Medicine
7. Recent Experimental Studies of Maternal Obesity, Diabetes during Pregnancy and the Developmental Origins of Cardiovascular Disease
   Kereliuk, Stephanie M., Dolinsky, Vernon W. · 2022 · International Journal of Molecular Sciences
8. Does metformin decrease blood pressure in patients with Type 2 diabetes intensively treated with insulin?
   Wulffelé, M. G., Kooy, A., Lehert, P., Bets, D., Donker, A. J. M., Stehouwer, C. D. A. · 2005 · Diabetic Medicine
9. New Clinical Markers Predictive of Cardiovascular Disease: The Role of Inflammatory Mediators
   Rackley, Charles E. · 2004 · Cardiology in Review